INSMED INC Increase (Decrease) in Inventories
INSMED INC (INSM) reported Increase (Decrease) in Inventories of $14.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- INSMED INC increase (decrease) in inventories for the quarter ending 2026-06-30 was $12.97M, a 160.73% increase year-over-year.
- INSMED INC increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.89M, a 84.72% increase year-over-year.
- INSMED INC increase (decrease) in inventories for the quarter ending 2025-12-31 was $11.76M, a 454.38% increase year-over-year.
- INSMED INC increase (decrease) in inventories for the quarter ending 2025-09-30 was $13.76M, a 109.44% increase year-over-year.
- INSMED INC increase (decrease) in inventories for fiscal 2025 was $31.52M, a 84.93% increase from fiscal 2024.
- INSMED INC increase (decrease) in inventories for fiscal 2024 was $17.04M, a 25.20% increase from fiscal 2023.
- INSMED INC increase (decrease) in inventories for fiscal 2023 was $13.61M, a 694.22% increase from fiscal 2022.
- INSMED INC increase (decrease) in inventories for fiscal 2022 was $1.71M, a 90.18% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.86M 10-Q · filed 2026-08-06 | $26.62M derived: sum of 3 quarters · filed 2026-08-06 | $40.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.89M 10-Q · filed 2026-05-07 | $13.65M derived: sum of 2 quarters · filed 2026-05-07 | $27.41M derived: sum of 3 quarters · filed 2026-05-07 | $32.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $11.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $25.52M derived: sum of 2 quarters · filed 2026-02-19 | $30.50M derived: sum of 3 quarters · filed 2026-08-06 | $31.52M 10-K · filed 2026-02-19 |
| 2025-09-30 | $13.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $18.73M derived: sum of 2 quarters · filed 2026-08-06 | $19.75M 10-Q · filed 2025-10-30 | $21.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.00M 10-Q · filed 2026-08-06 | $8.12M derived: sum of 3 quarters · filed 2026-08-06 | $14.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.02M 10-Q · filed 2026-05-07 | $3.14M derived: sum of 2 quarters · filed 2026-05-07 | $9.71M derived: sum of 3 quarters · filed 2026-05-07 | $17.47M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.69M derived: sum of 2 quarters · filed 2026-02-19 | $16.45M derived: sum of 3 quarters · filed 2026-02-19 | $17.04M 10-K · filed 2026-02-19 |
| 2024-09-30 | $6.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $14.32M derived: sum of 2 quarters · filed 2025-10-30 | $14.92M 10-Q · filed 2025-10-30 | $19.36M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $7.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $8.35M 10-Q · filed 2025-08-07 | $12.79M derived: sum of 3 quarters · filed 2026-02-19 | $13.88M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $598.00K 10-Q · filed 2025-05-08 | $5.03M derived: sum of 2 quarters · filed 2026-02-19 | $6.13M derived: sum of 3 quarters · filed 2026-02-19 | $13.02M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.53M derived: sum of 2 quarters · filed 2026-02-19 | $12.43M derived: sum of 3 quarters · filed 2026-02-19 | $13.61M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $7.99M derived: sum of 2 quarters · filed 2024-10-31 | $9.18M 10-Q · filed 2024-10-31 | $11.52M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.08M 10-Q · filed 2024-08-08 | $10.42M derived: sum of 3 quarters · filed 2025-02-20 | $10.52M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.19M 10-Q · filed 2024-05-09 | $3.52M derived: sum of 2 quarters · filed 2025-02-20 | $3.63M derived: sum of 3 quarters · filed 2025-02-20 | $5.14M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.44M derived: sum of 2 quarters · filed 2025-02-20 | $3.95M derived: sum of 3 quarters · filed 2025-02-20 | $1.71M 10-K · filed 2025-02-20 |
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $1.62M derived: sum of 2 quarters · filed 2023-10-26 | -$624.00K 10-Q · filed 2023-10-26 | -$1.76M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$724.00K 10-Q · filed 2023-08-03 | -$1.86M derived: sum of 3 quarters · filed 2024-02-22 | $5.17M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$2.24M 10-Q · filed 2023-05-04 | -$3.37M derived: sum of 2 quarters · filed 2024-02-22 | $3.66M derived: sum of 3 quarters · filed 2024-02-22 | $12.46M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $5.90M derived: sum of 2 quarters · filed 2024-02-22 | $14.70M derived: sum of 3 quarters · filed 2024-02-22 | $17.46M 10-K · filed 2024-02-22 |
| 2021-09-30 | $7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $15.83M derived: sum of 2 quarters · filed 2022-10-27 | $18.59M 10-Q · filed 2022-10-27 | $24.65M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $11.56M 10-Q · filed 2022-08-04 | $17.62M derived: sum of 3 quarters · filed 2023-02-23 | $25.58M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $2.75M 10-Q · filed 2022-05-05 | $8.82M derived: sum of 2 quarters · filed 2023-02-23 | $16.77M derived: sum of 3 quarters · filed 2023-02-23 | $21.60M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $14.02M derived: sum of 2 quarters · filed 2023-02-23 | $18.85M derived: sum of 3 quarters · filed 2023-02-23 | $21.18M 10-K · filed 2023-02-23 |
| 2020-09-30 | $7.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $12.78M derived: sum of 2 quarters · filed 2021-10-28 | $15.12M 10-Q · filed 2021-10-28 | $20.12M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $7.16M 10-Q · filed 2021-08-05 | $12.16M derived: sum of 3 quarters · filed 2022-02-17 | $15.31M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $2.33M 10-Q · filed 2021-05-06 | $7.33M derived: sum of 2 quarters · filed 2022-02-17 | $10.48M derived: sum of 3 quarters · filed 2022-02-17 | $17.96M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $8.15M derived: sum of 2 quarters · filed 2022-02-17 | $15.63M derived: sum of 3 quarters · filed 2022-02-17 | $21.28M 10-K · filed 2022-02-17 |
| 2019-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $10.63M derived: sum of 2 quarters · filed 2020-10-29 | $16.28M 10-Q · filed 2020-10-29 | $23.31M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $7.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.13M 10-Q · filed 2020-08-06 | $20.16M derived: sum of 3 quarters · filed 2021-02-25 | $20.16M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $5.65M 10-Q · filed 2020-04-30 | $12.68M derived: sum of 2 quarters · filed 2021-02-25 | $12.68M derived: sum of 3 quarters · filed 2021-02-25 | $12.68M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $7.03M derived: sum of 2 quarters · filed 2021-02-25 | $7.03M derived: sum of 3 quarters · filed 2021-02-25 | $7.03M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |